Bain Capital Life Sciences Investors’s Solid Biosciences SLDB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $98M | Hold |
9,808,819
| – | – | 5.83% | 6 |
|
|
2026
Q1 | $70.6M | Buy |
9,808,819
+1,897,150
| +24% | +$12.2M | 6.37% | 6 |
|
|
2025
Q4 | $44.6M | Hold |
7,911,669
| – | – | 3.42% | 6 |
|
|
2025
Q3 | $48.8M | Hold |
7,911,669
| – | – | 3.24% | 8 |
|
|
2025
Q2 | $38.5M | Hold |
7,911,669
| – | – | 4.82% | 7 |
|
|
2025
Q1 | $29.3M | Buy |
7,911,669
+3,877,087
| +96% | +$16.6M | 4.33% | 7 |
|
|
2024
Q4 | $16.1M | Hold |
4,034,582
| – | – | 1.9% | 11 |
|
|
2024
Q3 | $28.1M | Hold |
4,034,582
| – | – | 2.93% | 8 |
|
|
2024
Q2 | $22.9M | Hold |
4,034,582
| – | – | 2.51% | 10 |
|
|
2024
Q1 | $53.7M | Buy |
4,034,582
+904,160
| +29% | +$8.46M | 4.32% | 9 |
|
|
2023
Q4 | $19.2M | Hold |
3,130,422
| – | – | 1.84% | 14 |
|
|
2023
Q3 | $7.89M | Hold |
3,130,422
| – | – | 0.88% | 23 |
|
|
2023
Q2 | $16.4M | Hold |
3,130,422
| – | – | 1.69% | 19 |
|
|
2023
Q1 | $14.8M | Hold |
3,130,422
| – | – | 1.85% | 18 |
|
|
2022
Q4 | $16.8M | Buy |
3,130,422
+2,601,761
| +492% | +$17.1M | 1.88% | 17 |
|
|
2022
Q3 | $3.7M | Hold |
528,661
| – | – | 0.44% | 30 |
|
|
2022
Q2 | $4.88M | Hold |
528,661
| – | – | 0.57% | 29 |
|
|
2022
Q1 | $9.52M | Hold |
528,661
| – | – | 0.92% | 21 |
|
|
2021
Q4 | $13.9M | Hold |
528,661
| – | – | 1.1% | 21 |
|
|
2021
Q3 | $19M | Hold |
528,661
| – | – | 1.18% | 19 |
|
|
2021
Q2 | $29M | Hold |
528,661
| – | – | 1.9% | 13 |
|
|
2021
Q1 | $43.9M | Buy |
528,661
+57,971
| +12% | +$6.41M | 2.48% | 10 |
|
|
2020
Q4 | $53.5M | Buy |
470,690
+212,612
| +82% | +$13.4M | 3.36% | 9 |
|
|
2020
Q3 | $7.86M | Hold |
258,078
| – | – | 0.73% | 20 |
|
|
2020
Q2 | $11.3M | Hold |
258,078
| – | – | 1.19% | 15 |
|
|
2020
Q1 | $9.25M | Hold |
258,078
| – | – | 1.56% | 11 |
|
|
2019
Q4 | $17.2M | Hold |
258,078
| – | – | 2.57% | 8 |
|
|
2019
Q3 | $40M | Buy |
258,078
+125,448
| +95% | +$14.2M | 10.31% | 3 |
|
|
2019
Q2 | $11.4M | Hold |
132,630
| – | – | 5.81% | 4 |
|
|
2019
Q1 | $18.3M | Hold |
132,630
| – | – | 7.32% | 5 |
|
|
2018
Q4 | $53.3M | Hold |
132,630
| – | – | 18.22% | 3 |
|
|
2018
Q3 | $93.9M | Hold |
132,630
| – | – | 21.3% | 2 |
|
|
2018
Q2 | $70.9M | Hold |
132,630
| – | – | 22.21% | 2 |
|
|
2018
Q1 | $14.9M | Buy |
+132,630
| New | +$44.8M | 8.8% | 4 |
|
Other funds holding SLDB
RCM
PA
SL
AC
JT
RI
Bain Capital Life Sciences Investors's SLDB Position: Q2 2026 in Review
Bain Capital Life Sciences Investors held its Solid Biosciences (SLDB) position steady in Q2 2026 at 9,808,819 shares worth $98M. The position accounts for 5.83% of the portfolio, ranked #6.
Bain Capital Life Sciences Investors first reported a position in SLDB in Q1 2018 and has held it in 34 quarters since. 156 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.
- Bain Capital Life Sciences Investors held 9,808,819 shares of Solid Biosciences worth $98M as of Q2 2026.
- Bain Capital Life Sciences Investors left its Solid Biosciences share count unchanged in Q2 2026.
- Solid Biosciences made up 5.83% of Bain Capital Life Sciences Investors's portfolio in Q2 2026, its #6 holding.
- Bain Capital Life Sciences Investors first reported a position in Solid Biosciences in Q1 2018 and has held it in 34 quarters since.
- 156 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.
Based on Bain Capital Life Sciences Investors's 13F filing for Q2 2026, filed 14 Aug 2026.